Cerity Partners’s OKYO Pharma OKYO Stock Holding History

Cerity Partners’s Portfolio OKYO Stock Details OKYO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.6K	Hold	12,812	–	–	﹤0.01%	3181
2025 Q4	$26.5K	Hold	12,812	–	–	﹤0.01%	2835
2025 Q3	$25.6K	Hold	12,812	–	–	﹤0.01%	2717
2025 Q2	$32.9K	Hold	12,812	–	–	﹤0.01%	2580
2025 Q1	$16.3K	Hold	12,812	–	–	﹤0.01%	2453
2024 Q4	$14.7K	Hold	12,812	–	–	﹤0.01%	2407
2024 Q3	$13.1K	Hold	12,812	–	–	﹤0.01%	2516
2024 Q2	$15.2K	Sell	12,812 -500	-4%	-$700	﹤0.01%	2208
2024 Q1	$19.8K	Buy	13,312 +1,000	+8%	+$1.54K	﹤0.01%	2272
2023 Q4	$21.8K	Buy	+12,312	New	+$21.6K	﹤0.01%	1835

Other funds holding OKYO

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

EFG International Zurich $4.67B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cerity Partners's OKYO Position: Q1 2026 in Review

Cerity Partners held its OKYO Pharma (OKYO) position steady in Q1 2026 at 12,812 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3181.

Cerity Partners first reported a position in OKYO in Q4 2023 and has held it in 10 quarters since. The position peaked at $32.9K in Q2 2025. 12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

Cerity Partners held 12,812 shares of OKYO Pharma worth $20.6K as of Q1 2026.
Cerity Partners left its OKYO Pharma share count unchanged in Q1 2026.
OKYO Pharma made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #3181 holding.
Cerity Partners first reported a position in OKYO Pharma in Q4 2023 and has held it in 10 quarters since.
Cerity Partners's OKYO Pharma position peaked at $32.9K in Q2 2025.
12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.